Psagot Value Holdings Ltd. Gilead Sciences, Inc. Transaction History

Psagot Value Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $1,520 - $1,734	20 New	20 $2,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $4,923 - $6,169	-85 Closed	0 $0
Q4 2021 Mar 14, 2022	SELL	$64.88 - $73.64 $32,439 - $36,820	-500 Reduced 85.47%	85 $920,000
Q3 2021 Mar 07, 2022	BUY	$67.69 - $73.03 $39,598 - $42,722	585 New	585 $41,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.